A 12-month, Randomized, Efficacy and Safety Study of 0.5 mg Ranibizumab vs Laser in Chinese Diabetic Macular Edema (DME) Patients
Clinical trial NCT02259088 · COMPLETED
Trial details
- NCT number
- NCT02259088
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-05
- Primary completion
- 2017-01-17
- Enrollment
- 384
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.